Patents Assigned to ACES Pharma Inc.
  • Publication number: 20160158307
    Abstract: The present invention provides a family of novel cytotoxic pentapeptides, which show potent antitumor activities against several cancer lines. The antibody-drug conjugates prepared from those pentapeptides can efficiently kill cancer cells.
    Type: Application
    Filed: February 15, 2016
    Publication date: June 9, 2016
    Applicant: ACES Pharma Inc.
    Inventors: Shanghui Hu, Lucy Xiumin Zhao, Jinying Ning, Xufang Tian, Chao Li, Wei Hu, Xu Liu, Bonnie Y. Hu
  • Publication number: 20150284425
    Abstract: The present invention provides a family of novel cytotoxic pentapeptides, which show potent antitumor activities against several cancer lines. The antibody-drug conjugates prepared from those pentapeptides can efficiently kill cancer cells.
    Type: Application
    Filed: October 16, 2014
    Publication date: October 8, 2015
    Applicant: ACES Pharma Inc.
    Inventors: Shanghui Hu, Lucy Xiumin Zhao, Jinying Ning, Xufang Tian